RAAP Advocacy Highlight STOP: Accelerated Approval As A Proxy For High Drug Costs Is Misguided The Rare Access Action Project, (RAAP) submitted comments to the Oregon Health Authority’s (OHA) proposed renewal and amendment of its Section 1115 waiver for the July 1, 2022 – June 30, 2027, demonstration period… ...Read More RAAP is proud to have run the below ad in print papers as we work to protect innovations.
